Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

Qian Huang; Rui Xiao; Jing Lu; Yao Zhang; Liang Xu; Jie Gao; Jing Sun; Haiping Wang

doi:10.3389/fphar.2024.1532797

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

Front Pharmacol. 2024 Dec 12:15:1532797. doi: 10.3389/fphar.2024.1532797. eCollection 2024.

Authors

Qian Huang^#¹, Rui Xiao^#¹, Jing Lu², Yao Zhang², Liang Xu², Jie Gao², Jing Sun^{1

2}, Haiping Wang^{1

2}

Affiliations

¹ Department of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, China.
² Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.973182.].

Keywords: EMT; TGF-β/ALK/Smads; angiogenesis; endoglin; peritoneal fibrosis.

Publication types

Published Erratum

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by National Science Foundation for Young Scholars of China (Grant Nos 81500584 and 81200530), the Science and Technology Development Plan Program of Medicine and Health of Shandong Province (No. 202103050761), Jinan Science and Technology Development Plan - Clinical Medicine Technology Innovation Plan (No. 202225049) and Young Scientist Fund Training Program of Shandong First Medical University (Shandong Academy of Medical Sciences) (No. 202201-062).